These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 17159300
41. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients. Vijayaraghavan B, Padmanabhan G, Ramanathan K. Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919 [Abstract] [Full Text] [Related]
42. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Lee EY, Lee BW, Kim D, Lee YH, Kim KJ, Kang ES, Cha BS, Lee EJ, Lee HC. Acta Diabetol; 2011 Jun; 48(2):167-72. PubMed ID: 21153482 [Abstract] [Full Text] [Related]
43. Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy. Hiramatsu Y, Shimizu I, Omori Y, Nakabayashi M, JGA (Japan Glycated Albumin) Study Group. Endocr J; 2012 Jun; 59(2):145-51. PubMed ID: 22166921 [Abstract] [Full Text] [Related]
44. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis. Ueda S, Nagai K, Yokota N, Hirose D, Mori H, Noma Y, Doi T, Minakuchi J. J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746 [Abstract] [Full Text] [Related]
45. Clinical usefulness of glycated albumin and glycated albumin-to-glycated hemoglobin ratio of gestational diabetes mellitus in late pregnancy for predicting infant complications. Sugawara D, Sato H, Makita E, Kuwata T, Takagi K, Ichihashi K. Pediatr Neonatol; 2022 May; 63(3):239-246. PubMed ID: 35185003 [Abstract] [Full Text] [Related]
46. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [Abstract] [Full Text] [Related]
47. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y, Osaka CKD Expert Research Group. J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743 [Abstract] [Full Text] [Related]
48. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis. Yajima T, Yajima K, Hayashi M, Takahashi H, Yasuda K. Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154 [Abstract] [Full Text] [Related]
49. Predictive value of the glycated albumin versus glycosylated hemoglobin in follow-up of glucose homeostasis in hemodialysis-maintained type-2 diabetic patients. Ahmed E, El Zahraa Sayed Bokhary F, Ismail S, Mahmoud Abd El Hameed W. Endocr Regul; 2022 Feb 18; 56(1):10-21. PubMed ID: 35180823 [Abstract] [Full Text] [Related]
50. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus. Wang N, Xu Z, Han P, Li T. Diabetes Metab Res Rev; 2017 Feb 18; 33(2):. PubMed ID: 27537245 [Abstract] [Full Text] [Related]
51. The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Jeon WS, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Diabetes Res Clin Pract; 2016 Jun 18; 116():46-53. PubMed ID: 27321316 [Abstract] [Full Text] [Related]
52. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan. Hsu P, Ai M, Kanda E, Yu NC, Chen HL, Chen HW, Cheng MH, Kohzuma T, Schaefer EJ, Yoshida M. Atherosclerosis; 2015 Sep 18; 242(1):327-33. PubMed ID: 26247684 [Abstract] [Full Text] [Related]
53. Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome. Kitamura T, Otsuki M, Tamada D, Tabuchi Y, Mukai K, Morita S, Kasayama S, Bando Y, Shimomura I, Koga M. Clin Biochem; 2014 Dec 18; 47(18):279-82. PubMed ID: 25218816 [Abstract] [Full Text] [Related]
54. Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetes. Lee YH, Kown MH, Kim KJ, Lee EY, Kim D, Lee BW, Kang ES, Cha BS, Lee HC. PLoS One; 2014 Dec 18; 9(9):e108772. PubMed ID: 25265016 [Abstract] [Full Text] [Related]
55. Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol. Ohigashi M, Osugi K, Kusunoki Y, Washio K, Matsutani S, Tsunoda T, Matsuo T, Konishi K, Katsuno T, Namba M, Koyama H. J Diabetes Investig; 2021 Jun 18; 12(6):940-949. PubMed ID: 33058513 [Abstract] [Full Text] [Related]
56. Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Shen Y, Lu L, Ding FH, Sun Z, Zhang RY, Zhang Q, Yang ZK, Hu J, Chen QJ, Shen WF. Cardiovasc Diabetol; 2013 Nov 08; 12():165. PubMed ID: 24209601 [Abstract] [Full Text] [Related]
57. [Performance characteristics of glycated albumin and its clinical usefulness in diabetic patients on hemodialysis]. Park HI, Kim YS, Lee J, Kim Y, Shin SJ. Korean J Lab Med; 2009 Oct 08; 29(5):406-14. PubMed ID: 19893349 [Abstract] [Full Text] [Related]
58. Effects of growth hormone excess on glycated albumin concentrations: Analysis in acromegalic patients. Tamada D, Otsuki M, Kitamura T, Oshino S, Saitoh Y, Shimomura I, Koga M. Clin Chim Acta; 2015 Feb 02; 440():93-6. PubMed ID: 25447699 [Abstract] [Full Text] [Related]
59. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Kumeda Y, Inaba M, Shoji S, Ishimura E, Inariba H, Yabe S, Okamura M, Nishizawa Y. Clin Endocrinol (Oxf); 2008 Oct 02; 69(4):556-61. PubMed ID: 18248645 [Abstract] [Full Text] [Related]
60. Variability in glycated albumin levels predicts the progression of diabetic nephropathy. Park SB, Kim SS, Kim IJ, Nam YJ, Ahn KH, Kim JH, Jeon YK, Kim BH, Song SH, Kwak IS, Lee EK, Kim YK. J Diabetes Complications; 2017 Jun 02; 31(6):1041-1046. PubMed ID: 28396158 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]